Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring the Who, When, and How for Stem Cell Therapy
•Download as PPT, PDF•
0 likes•8 views
Philip James Tozer, MBBS, MD(Res), FRCS, Krisztina Barbara Gecse, MD, PhD, and Jordi Rimola, MD, PhD, discuss complex perianal fistula in this CME activity titled "Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring the Who, When, and How for Stem Cell Therapy." For the full presentation, please visit us at www.peervoice.com/GWC870.
Report
Share
Report
Share
Recommended
Case Study Challenge: Managing FLT3-ITD–Positive AML
Michael Heuser, MD, discusses AML in this IME activity titled "Case Study Challenge: Managing FLT3-ITD–Positive AML." For the full presentation, please visit us at www.peervoice.com/APW870.
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
Jonathan W. Riess, MD, MS, Mary Beth Beasley, MD, and Gerard A. Silvestri, MD, MS, Master FCCP, discuss NSCLC in this CME activity titled "The Central Role of the Pathologist in Detecting MET Alterations: Enabling Multidisciplinary Teams to Do More With Less in NSCLC." For the full presentation, please visit us at www.peervoice.com/QHY870.
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
Xavier Montalban, MD, PhD, and Jiwon Oh, MD, PhD, FRCPC, discuss multiple sclerosis in this CE activity titled "Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?" For the full presentation, please visit us at www.peervoice.com/BBT870.
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Lindsey Roeker, MD discusses chronic lymphocytic leukaemia in this CME activity titled "Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimilar Agents." For the full presentation, please visit us at www.peervoice.com/HZH870.
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
Sara Hurvitz, MD, Hope S. Rugo, MD, FASCO, and Paolo Tarantino, MD, discuss breast cancer in this CME activity titled "A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Advanced Breast Cancer." For the full presentation, please visit us at www.peervoice.com/UGT870.
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Christian Récher, MD, PhD, Pau Montesinos, MD, PhD, and Christian Thiede, MD, discuss acute myeloid leukaemia in this IME activity titled "Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Optimising Our First-Line Approaches With Current and Novel Therapeutics." For the full presentation, please visit us at www.peervoice.com/GYE870.
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Maria Craig, MBBS, PhD, FRACP, MMed(ClinEpid) and Timothy Barrett, MB, BS, PhD discuss type 2 diabetes in children and adolescents in this CE activity titled "Treating T2D in People of Younger Age in This Day and Age: How Would You Manage These Children and Adolescents With T2D?" For the full presentation, please visit us at www.peervoice.com/GBR870.
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Thomas Powles, MBBS, MRCP, MD, discusses urothelial carcinoma in this CE activity titled "Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best Practices and Future Directions in Maintenance Therapy." For the full presentation, please visit us at www.peervoice.com/NYE870.
Recommended
Case Study Challenge: Managing FLT3-ITD–Positive AML
Michael Heuser, MD, discusses AML in this IME activity titled "Case Study Challenge: Managing FLT3-ITD–Positive AML." For the full presentation, please visit us at www.peervoice.com/APW870.
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
Jonathan W. Riess, MD, MS, Mary Beth Beasley, MD, and Gerard A. Silvestri, MD, MS, Master FCCP, discuss NSCLC in this CME activity titled "The Central Role of the Pathologist in Detecting MET Alterations: Enabling Multidisciplinary Teams to Do More With Less in NSCLC." For the full presentation, please visit us at www.peervoice.com/QHY870.
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
Xavier Montalban, MD, PhD, and Jiwon Oh, MD, PhD, FRCPC, discuss multiple sclerosis in this CE activity titled "Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?" For the full presentation, please visit us at www.peervoice.com/BBT870.
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Lindsey Roeker, MD discusses chronic lymphocytic leukaemia in this CME activity titled "Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimilar Agents." For the full presentation, please visit us at www.peervoice.com/HZH870.
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
Sara Hurvitz, MD, Hope S. Rugo, MD, FASCO, and Paolo Tarantino, MD, discuss breast cancer in this CME activity titled "A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Advanced Breast Cancer." For the full presentation, please visit us at www.peervoice.com/UGT870.
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Christian Récher, MD, PhD, Pau Montesinos, MD, PhD, and Christian Thiede, MD, discuss acute myeloid leukaemia in this IME activity titled "Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Optimising Our First-Line Approaches With Current and Novel Therapeutics." For the full presentation, please visit us at www.peervoice.com/GYE870.
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Maria Craig, MBBS, PhD, FRACP, MMed(ClinEpid) and Timothy Barrett, MB, BS, PhD discuss type 2 diabetes in children and adolescents in this CE activity titled "Treating T2D in People of Younger Age in This Day and Age: How Would You Manage These Children and Adolescents With T2D?" For the full presentation, please visit us at www.peervoice.com/GBR870.
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Thomas Powles, MBBS, MRCP, MD, discusses urothelial carcinoma in this CE activity titled "Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best Practices and Future Directions in Maintenance Therapy." For the full presentation, please visit us at www.peervoice.com/NYE870.
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
Jeffrey Szer, MBBS, FRACP, discusses PNH in this IME activity titled "The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria." For the full presentation, please visit us at www.peervoice.com/ZHK870.
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
Asma Khalil, MBBCh, MD(Res), FRCOG, MSc(Epi), and Enrico Lopriore, MD, PhD, discuss haemolytic disease of the fetus and newborn in this CE activity titled "When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn." For the full presentation, please visit us at www.peervoice.com/BKD870.
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
Fatos Pinar Topsever, MD and Jennifer Green, MD discuss CKD in T2DM in this CME activity titled "CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes." For the full presentation, please visit us at www.peervoice.com/QKR870.
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Lisa Licitra, MD, and Barbara Burtness, MD, discuss head and neck cancer in this CE activity titled "Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?" For the full presentation, please visit us at www.peervoice.com/YZV870.
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Dirk Arnold, MD, Chiara Cremolini, MD, PhD, and Nicola Normanno, MD, discuss metastatic colorectal cancer in this CE activity titled "Navigating Decisions With Limited Tools: A Review of Best Practices in Managing Metastatic Colorectal Cancer." For the full presentation, please visit us at www.peervoice.com/RAS870.
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Ali Aamer Habib, MD, and Martijn Tannemaat, MD, PhD, discuss generalised myasthenia gravis in this CE activity titled "Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis." For the full presentation, please visit us at www.peervoice.com/JEG870.
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Jonathan W. Goldman, MD, Xiuning Le, MD, PhD, and Diana N. Ionescu, MD, discuss NSCLC in this IME activity titled "Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC." For the full presentation, please visit us at www.peervoice.com/HPP870.
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Javed Butler, MD, MPH, MBA, Michael Böhm, MD, Alexandre Mebazaa, MD, PhD, and Antoni Bayés-Genís, MD, PhD, FESC, FHFA, discuss heart failure in this CE activity titled "Practical Perspectives and Straightforward Strategies for Optimising GDMT in HFrEF: The Role of ARNI as a Fundamental Building Block." For the full presentation, please visit us at www.peervoice.com/QJJ870.
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
Bertrand Tombal, MD, PhD, Edmund Chiong, MBBS, PhD, FRCS / FAMS, and Louise Emmett, MBChB, MD, discuss prostate cancer in this IME activity titled "MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optimise Outcomes." For the full presentation, please visit us at www.peervoice.com/EUM870.
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Wisia Wedzicha, MD, FRCP and Alberto Papi, MD discuss chronic obstructive pulmonary disease in this [CME] activity titled "Taking the Evidence from Paper to Practice: Shared Perspectives on Practical Considerations in Comprehensive COPD Care." For the full presentation, please visit us at www.peervoice.com/ZFW870.
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Nils Erik Gilhus, MD, PhD, and Sarah Hoffmann, MD, PhD, MSc, discuss generalised myasthenia gravis in this CE activity titled "Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Therapy in Generalised Myasthenia Gravis." For the full presentation, please visit us at www.peervoice.com/PBV870.
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
Marwan Fakih, MD, discusses colorectal cancer in this CME activity titled "The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Second Line." For the full presentation, please visit us at www.peervoice.com/SSC870.
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Marwan Fakih, MD, Tanios Bekaii-Saab, MD, and Dustin Deming, MD, discuss colorectal cancer in this CME activity titled "Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC." For the full presentation, please visit us at www.peervoice.com/AQR870.
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
David M. G. Halpin, MB BS, DPhil, FERS discusses chronic obstructive pulmonary disease in this CME activity titled "The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of Disability and Death." For the full presentation, please visit us at www.peervoice.com/UWS870.
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
Ana C. Garrido-Castro, MD and Sarah L. Sammons, MD discuss breast cancer in this CME activity titled "TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Significance of the Construct." For the full presentation, please visit us at www.peervoice.com/JJH870.
Building a Better Approach to Obesity Care in Our Clinical Practices
Carel le Roux, MD, PhD, discusses obesity in this CME activity titled "Building a Better Approach to Obesity Care in Our Clinical Practices." For the full presentation, please visit us at www.peervoice.com/HPE870.
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Laurent Servais, MD, PhD and Giovanni Baranello, MD, PhD discuss the clinical presentation of hypotonia in this IME activity titled "Catch Them Before They Fall: A Call to Action for Comprehensive Testing for Hypotonia in Paediatric Patients." For the full presentation, please visit us at www.peervoice.com/SNX870.
Radioligand Therapy and Therapeutic Sequencing in mCRPC
Elena Castro, MD, PhD, discusses prostate cancer in this IME activity titled "Radioligand Therapy and Therapeutic Sequencing in mCRPC." For the full presentation, please visit us at www.peervoice.com/AKT870.
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Claus Vogelmeier, MD, and Nicola Hanania, MD, MS, discuss chronic obstructive pulmonary disease in this CE activity titled "Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD." For the full presentation, please visit us at www.peervoice.com/JHP870.
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
Perry Elliott, MD, FRCP and Elena Arbelo, MD, PhD, MSc discuss hypertrophic cardiomyopathy in this CE activity titled "What’s New and What’s Next? Expanding Our Understanding of HCM in 2023." For the full presentation, please visit us at www.peervoice.com/UET870.
CDSCO and Phamacovigilance {Regulatory body in India}
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
More Related Content
More from PeerVoice
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
Jeffrey Szer, MBBS, FRACP, discusses PNH in this IME activity titled "The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria." For the full presentation, please visit us at www.peervoice.com/ZHK870.
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
Asma Khalil, MBBCh, MD(Res), FRCOG, MSc(Epi), and Enrico Lopriore, MD, PhD, discuss haemolytic disease of the fetus and newborn in this CE activity titled "When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn." For the full presentation, please visit us at www.peervoice.com/BKD870.
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
Fatos Pinar Topsever, MD and Jennifer Green, MD discuss CKD in T2DM in this CME activity titled "CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes." For the full presentation, please visit us at www.peervoice.com/QKR870.
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Lisa Licitra, MD, and Barbara Burtness, MD, discuss head and neck cancer in this CE activity titled "Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?" For the full presentation, please visit us at www.peervoice.com/YZV870.
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Dirk Arnold, MD, Chiara Cremolini, MD, PhD, and Nicola Normanno, MD, discuss metastatic colorectal cancer in this CE activity titled "Navigating Decisions With Limited Tools: A Review of Best Practices in Managing Metastatic Colorectal Cancer." For the full presentation, please visit us at www.peervoice.com/RAS870.
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Ali Aamer Habib, MD, and Martijn Tannemaat, MD, PhD, discuss generalised myasthenia gravis in this CE activity titled "Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis." For the full presentation, please visit us at www.peervoice.com/JEG870.
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Jonathan W. Goldman, MD, Xiuning Le, MD, PhD, and Diana N. Ionescu, MD, discuss NSCLC in this IME activity titled "Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC." For the full presentation, please visit us at www.peervoice.com/HPP870.
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Javed Butler, MD, MPH, MBA, Michael Böhm, MD, Alexandre Mebazaa, MD, PhD, and Antoni Bayés-Genís, MD, PhD, FESC, FHFA, discuss heart failure in this CE activity titled "Practical Perspectives and Straightforward Strategies for Optimising GDMT in HFrEF: The Role of ARNI as a Fundamental Building Block." For the full presentation, please visit us at www.peervoice.com/QJJ870.
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
Bertrand Tombal, MD, PhD, Edmund Chiong, MBBS, PhD, FRCS / FAMS, and Louise Emmett, MBChB, MD, discuss prostate cancer in this IME activity titled "MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optimise Outcomes." For the full presentation, please visit us at www.peervoice.com/EUM870.
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Wisia Wedzicha, MD, FRCP and Alberto Papi, MD discuss chronic obstructive pulmonary disease in this [CME] activity titled "Taking the Evidence from Paper to Practice: Shared Perspectives on Practical Considerations in Comprehensive COPD Care." For the full presentation, please visit us at www.peervoice.com/ZFW870.
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Nils Erik Gilhus, MD, PhD, and Sarah Hoffmann, MD, PhD, MSc, discuss generalised myasthenia gravis in this CE activity titled "Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Therapy in Generalised Myasthenia Gravis." For the full presentation, please visit us at www.peervoice.com/PBV870.
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
Marwan Fakih, MD, discusses colorectal cancer in this CME activity titled "The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Second Line." For the full presentation, please visit us at www.peervoice.com/SSC870.
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Marwan Fakih, MD, Tanios Bekaii-Saab, MD, and Dustin Deming, MD, discuss colorectal cancer in this CME activity titled "Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC." For the full presentation, please visit us at www.peervoice.com/AQR870.
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
David M. G. Halpin, MB BS, DPhil, FERS discusses chronic obstructive pulmonary disease in this CME activity titled "The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of Disability and Death." For the full presentation, please visit us at www.peervoice.com/UWS870.
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
Ana C. Garrido-Castro, MD and Sarah L. Sammons, MD discuss breast cancer in this CME activity titled "TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Significance of the Construct." For the full presentation, please visit us at www.peervoice.com/JJH870.
Building a Better Approach to Obesity Care in Our Clinical Practices
Carel le Roux, MD, PhD, discusses obesity in this CME activity titled "Building a Better Approach to Obesity Care in Our Clinical Practices." For the full presentation, please visit us at www.peervoice.com/HPE870.
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Laurent Servais, MD, PhD and Giovanni Baranello, MD, PhD discuss the clinical presentation of hypotonia in this IME activity titled "Catch Them Before They Fall: A Call to Action for Comprehensive Testing for Hypotonia in Paediatric Patients." For the full presentation, please visit us at www.peervoice.com/SNX870.
Radioligand Therapy and Therapeutic Sequencing in mCRPC
Elena Castro, MD, PhD, discusses prostate cancer in this IME activity titled "Radioligand Therapy and Therapeutic Sequencing in mCRPC." For the full presentation, please visit us at www.peervoice.com/AKT870.
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Claus Vogelmeier, MD, and Nicola Hanania, MD, MS, discuss chronic obstructive pulmonary disease in this CE activity titled "Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD." For the full presentation, please visit us at www.peervoice.com/JHP870.
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
Perry Elliott, MD, FRCP and Elena Arbelo, MD, PhD, MSc discuss hypertrophic cardiomyopathy in this CE activity titled "What’s New and What’s Next? Expanding Our Understanding of HCM in 2023." For the full presentation, please visit us at www.peervoice.com/UET870.
More from PeerVoice (20)
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
Building a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical Practices
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Radioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPC
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
Recently uploaded
CDSCO and Phamacovigilance {Regulatory body in India}
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Drug Discovery and Development .....
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Knee anatomy and clinical tests 2024.pdf
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Top 10 Best Ayurvedic Kidney Stone Syrups in India
we have mentioned the best 10 ayurvedic Kidney Stone Syrups. You can check all these products and choose the best one for yourself.
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
PPT RELATED TO ARTHROLOGY ACCORDING TO NCISM AYURVEDA
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
KDIGO 2024 guidelines for diabetologists
KDIGO guidelines 2024 for evaluation and management of CKD, related to diabetes and management of diabetic kidney disease
NVBDCP.pptx Nation vector borne disease control program
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Non-respiratory Functions of the Lungs.pdf
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Are There Any Natural Remedies To Treat Syphilis.pdf
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeProf. Marcus Renato de Carvalho
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Gram Stain introduction, principle, Procedure
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Valuable Content of Human Anatomy and Physiology of Urinary system as per PCI Syllabus for Pharmacy and PharmD Students.
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications. Reference - ASCRS textbook of colorectal surgery, Anorectal physiology - lucia olivia.
Bailey and love- 28th edition
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Swisschem Dermacare has mentioned the List of The Best Antifungal Soap In India 2022. All of these soaps are trusted by various Dermatology Experts.
Recently uploaded (20)
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications